Résultats de la recherche - Liève Brochez
- Résultat(s) 1 - 20 résultats de 27
- Aller à la page suivante
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Phase 2 Trial of Nivolumab Combined With Stereotactic Body Radiation Therapy in Patients With Metastatic or Locally Advanced Inoperable Melanoma par Nora Sundahl, Teofila Seremet, Jo Van Dorpe, Bart Neyns, Liesbeth Ferdinande, Annabel Meireson, Liève Brochez, Vibeke Krüse, Piet Ost
Publié 2019Artigo -
11
Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanoma par Inès Chevolet, Reinhart Speeckaert, Max Schreuer, Bart Neyns, Olga Krysko, Claus Bachert, Mireille Van Gele, Nanja van Geel, Liève Brochez
Publié 2015Artigo -
12
-
13
Characterization of the<i>in vivo</i>immune network of IDO, tryptophan metabolism, PD-L1, and<i>CTLA-4</i>in circulating immune cells in melanoma par Inès Chevolet, Reinhart Speeckaert, Max Schreuer, Bart Neyns, Olga Krysko, Claus Bachert, Benjamin Hennart, Delphine Allorge, Nanja van Geel, Mireille Van Gele, Liève Brochez
Publié 2015Artigo -
14
A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma pa... par Yanina Jansen, Vibeke Krüse, Jurgen Corthals, Kelly Schats, Pieter‐Jan van Dam, Teofila Seremet, Carlo Heirman, Liève Brochez, Mark Kockx, Kris Thielemans, Bart Neyns
Publié 2020Artigo -
15
Immune checkpoint blockade for organ transplant patients with advanced cancer: how far can we go? par Pauline De Bruyn, Dirk Van Gestel, Piet Ost, Vibeke Krüse, Liève Brochez, Hans Van Vlierberghe, Arnaud Devresse, V. del Mármol, Alaín Le Moine, Sandrine Aspeslagh
Publié 2019Revisão -
16
Cancer risk in immune-mediated inflammatory diseases (IMID) par Rudi Beyaert, Laurent Beaugerie, Gert Van Assche, Liève Brochez, Jean‐Christophe Renauld, M. Viguier, Véronique Cocquyt, Guy Jérusalem, Jean‐Pascal Machiels, Hans Prenen, Pierre Masson, Édouard Louis, Filip De Keyser
Publié 2013Revisão -
17
Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients par Reinhart Speeckaert, Karim Vermaelen, Nanja van Geel, Philippe Autier, Jo Lambert, Marc Haspeslagh, Mireille Van Gele, Kris Thielemans, Bart Neyns, Nathalie Roche, Natacha Verbeke, Philippe Deron, Marijn M. Speeckaert, Liève Brochez
Publié 2011Artigo -
18
Checkpoint Inhibitors in Combination With Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors par Mathieu Spaas, Nora Sundahl, Vibeke Krüse, Sylvie Rottey, Daan De Maeseneer, Fréderic Duprez, Yolande Lievens, Veerle Surmont, Liève Brochez, Dries Reynders, Willeke Danckaert, Els Goetghebeur, Robbe Van den Begin, Dirk Van Gestel, Vincent Renard, Piet Dirix, Piet Ost
Publié 2023Artigo -
19
Diagnosis and Treatment of Dermatofibrosarcoma Protuberans. European Interdisciplinary Guideline – update 2024 par Philippe Saïag, Célèste Lebbé, Liève Brochez, Jean‐François Emile, Ana‐Maria Forsea, Catherine Harwood, Axel Hauschild, Antoine Italiano, Lidija Kandolf, Nicole WJ Kelleners-Smeets, Aimilios Lallas, Ulrike Leiter, B. Llombart, Caterina Longo, Josep Malvehy, Željko Mijušković, D. Moreno‐Ramírez, Klara Mosterd, Luca Tagliaferri, Selma Ugurel, Ricardo Vieira, Iris Zalaudek, Claus Garbe
Publié 2025Revisão -
20
Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls melanogenesis and melanoma progression par Geertrui Denecker, Niels Vandamme, Özden Akay, Dana Koludrović, Joachim Taminau, Kelly Lemeire, Alexander Gheldof, Bram De Craene, Mireille Van Gele, Liève Brochez, Girish Mallya Udupi, Máirín Rafferty, Balázs Bálint, William M. Gallagher, G. Ghanem, Danny Huylebroeck, Jody J. Haigh, Joost van den Oord, Lionel Larue, Irwin Davidson, Jean‐Christophe Marine, Geert Berx
Publié 2014Artigo
Outils de recherche:
Sujets similaires
Medicine
Internal medicine
Biology
Cancer
Cancer research
Melanoma
Pathology
Immunology
Oncology
Dermatology
Immune system
Gene
Genetics
Biochemistry
Cell biology
Amino acid
Guideline
Immunotherapy
Indoleamine 2,3-dioxygenase
Tryptophan
Clinical trial
Disease
Environmental health
Nivolumab
Population
Radiology
Skin cancer
Cancer cell
Cell culture
Chemotherapy